Lumacaftor / ivacaftor

BNF:

Not listed

Status:

Do Not Prescribe (DNP)

Decision Date:

August 2016

Comments

DO NOT PRESCRIBE (DNP): NICE TA398 for treating cystic fibrosis in people 12 years and older who are homozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator gene. (Decision date - August 2016)   

Black Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

search again